This exceptional group of organizations has aligned to further efforts dedicated to the discovery, development and the seeking of regulatory approval for biological markers (i.e. biomarkers) that support new drug development, preventive medicine and medical diagnostics.
Working to support research and guide clinical practice is the main goal of The Biomarkers Consortium. This collaborative effort ensures that the voice of all stakeholders involved in biomarker research is heard and contributes to strides made in support of promising initiatives undertaken by The Consortium in areas such as cancer, immunity & inflammation, metabolic disorders and neuroscience.
Become a part of the growing list of contributing members from industry, foundations, professional associations and patient advocacy organizations, working together along with our government colleagues from the National Institutes of Health and U.S. Food and Drug Administration to achieve a new era of predictive, preventive and personalized medicine through biomarker research.
Our current list of Contributing Members include: